Highlights Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 16:00:26 2025-12-09 EST			5-day change	1st Jan Change
96.89 ^USD	-2.06%		-4.10%	-2.60%

06:10am	HSBC Adjusts Price Target on Merck & Co. to $120 From $100, Maintains Buy Rating	MT
12-09	Formycon Secures Additional Commercialization Partnership for Keytruda Biosimilar	DP

Highlights

Formycon Secures Additional Commercialization Partnership for Keytruda Biosimilar	12-09	DP
Weight-loss drug developers line up to tap lucrative market as competition heats up	12-08	RE
Global markets live: Netflix, Visa, Airbus, Ferrovial, Leonardo…	12-05
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case -- Update	12-04	DJ
Halozyme Wins German Patent Injunction Blocking Merck's Subcutaneous Keytruda	12-04	MT
Correction to Halozyme Granted Injunction Against Merck & Co. Article	12-04	DJ
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case	12-04	DJ
Halozyme wins preliminary injunction against Merck's Keytruda SC in Germany	12-04	RE
Merck says Exzolt Cattle-CA1 to be available by prescription in Q1 2026	12-04	RE
FDA conditionally approves topical drug for cattle against New World screwworm, fever tick	12-04	RE
Trump 'garbage' rhetoric about Somalis draws cheers from administration, silence from Republicans and alarm from critics	12-04	RE
Ready or Not It's Coming	12-02
Sector Update: Health Care Stocks Decline Late Afternoon	12-01	MT
Sector Update: Health Care Stocks Decline Monday Afternoon	12-01	MT
Merck seeks up to $8 billion in US bond sale tied to Cidara deal - Bloomberg News	12-01	RE
Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025	12-01	CI
Centers for Medicare & Medicaid Services Unveils $12 Billion Net Savings From Reduction in Drug Prices	11-26	MT
Weight-loss drug developers line up to tap lucrative market as competition heats up	11-25	RE
Sector Update: Health Care Stocks Advance Premarket Monday	11-24	MT
Trading on Whispers Alone	11-24
Merck Urges Shareholders to Reject Deep-Discount Mini-Tender Offer	11-24	MT
FDA approves Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph), each with Padcev (enfortumab vedotin-ejfv)	11-21	RE
FDA Approves Merck and KEYTRUDA (Pembrolizumab) and KEYTRUDA QLEX (Pembrolizumab and Berahyaluronidase Alfa-Pmph	11-21	CI
Pfizer, Astellas Say FDA Approves Padcev-Keytruda Combo in Bladder Cancer	11-21	MT
AnaptysBio shares tumble after legal fight with GSK over cancer drug license	11-21	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Merck to Buy Verona Pharma for About $10B

July 09, 2025 at 12:30 pm